This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Medicine purchases: ATC
A07EC01
1 out of 7 registries used, show all original rules.
12300
Check minimum number of events
Min. number of events
3
12300
Include endpoints None
12300
Remove individuals based on genotype QC
11942
RX_A07EC01
Control definitions
Control exclude
IBD_DRUGS
Extra metadata
First used in FinnGen datafreeze
DF4
Not enough data for upset plot.
Or the full data table
Similar endpoints
↥List of similar endpoints to
Sulfasalazine
based on the number of shared cases.
Broader endpoints:
- Inflammatory bowel disease treatment related agents
- First line medication for Crohn's disease
- Any prescribed medicine buy
Narrower endpoints:
None
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 11942 | 7195 | 4747 |
| Unadjusted prevalence (%) | 2.90 | 3.12 | 2.61 |
| Mean age at first event (years) | 46.81 | 45.30 | 49.09 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: RX_A07EC01 – Sulfasalazine
GWS hits:
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Sulfasalazine
↥Endpoint not on priority list, no data to show.